Clinical Trials

(PEAK) A PHASE 3 RANDOMIZED, OPEN-LABEL, MULTICENTER CLINICAL STUDY OF CGT9486+SUNITINIB VS SUNITINIB IN SUBJECTS WITH LOCALLY ADVANCED, UNRESECTABLE OR METASTATIC GASTROINTESTINAL STROMAL TUMORS

Link : https://www.clinicaltrials.gov/ct2/show/NCT05208047
Status : RECRUITING
Population : GIST
Description : Sunitinib +/- CGT9486
PI : A. Razak
Centers Opened : Princess Margaret Cancer Centre
Phase : III
IIST/Pharma : Pharma